Approval · Notice of Compliance 6622 · 2005
CLONAPAM: Notice of Compliance 6622
Issued April 25, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6622
- Date
- April 25, 2005
- Company
- Valeant Canada LpLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Anticonvulsant
- Canadian reference product
- RIVOTRIL (Hoffmann-La Roche Limited)
Products in this notice
Medicinal ingredients
- CLONAZEPAM 0.5 MG per TAB
- CLONAZEPAM 1 MG per TAB
- CLONAZEPAM 2 MG per TAB